Details for New Drug Application (NDA): 020574
✉ Email this page to a colleague
NDA 020574 describes GYNE-LOTRIMIN 3, which is a drug marketed by Bayer Healthcare Llc and is included in three NDAs. Additional details are available on the GYNE-LOTRIMIN 3 profile page.
The generic ingredient in GYNE-LOTRIMIN 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
The generic ingredient in GYNE-LOTRIMIN 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
Summary for 020574
| Tradename: | GYNE-LOTRIMIN 3 |
| Applicant: | Bayer Healthcare Llc |
| Ingredient: | clotrimazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020574
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;VAGINAL | Strength | 2% | ||||
| Approval Date: | Nov 24, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
